Avalo Therapeutics Inc expected to post a loss of $1.10 a share - Earnings Preview

Avalo Therapeutics

03/11/2023 14:50

* Avalo Therapeutics Inc  AVTX.OQ   AVTX.O  is expected
to show a
fall in quarterly revenue when it reports  results 
    * The Rockville Maryland-based  company is expected to
report  a
93.3% decrease in revenue to $1 million from $14.95 million a
year ago, according to the estimate from one analyst, based on
LSEG data. 
    * ​Refinitiv's mean analyst estimate for Avalo Therapeutics
Inc is
for a loss of $1.10 per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated November 3 at 14:50 GMT.  All
figures in US dollars  unless otherwise stated